OR WAIT null SECS
June 21, 2017
FDA Commissioner Scott Gottlieb announced the agency will hold a public meeting on drug competition as part of its Drug Competition Action Plan.
June 20, 2017
The European Commission approved Rixathon for use in all indications of its reference medicine, MabThera.
June 12, 2017
The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval.
June 07, 2017
The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods for predictive design.
June 06, 2017
Takeda will build a new production facility at its existing Grange Castle site in Ireland.
June 02, 2017
As cost pressures mount as a result of multiple biologics being developed for the same indication, manufacturers can harness process efficiencies to maintain the value of legacy products.
Industry experts discuss best practices for dissolution testing of poorly soluble, immediate-release, and controlled-release formulations and the different analytical approaches used.
Modern air jet milling can be used to investigate the feasibility of micronization as a solubilization approach in formulation development.
Efficient synthesis of complex cannabinoids is possible while avoiding marijuana cultivation.
May 31, 2017
Microdermics will focus on product development and clinical activities of new drug delivery methods, while Vetter’s primary role will be in the fill and finish aspect.
